Bram C. Agema is an author at Erasmus MC Cancer Institute.
Publications per year
2022–2022
1
1
Improving the tolerability of osimertinib by identifying its toxic limit
Bram C. Agema, G. Veerman, C. Steendam et al. · Therapeutic Advances in Medical Oncology · 2022 · 36 citations · Full text
Rows per page
1–1 of 1